Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 4
Submit an article Journal homepage
821
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Novel monoclonal antibodies for therapy of multiple sclerosis

Benjamin KnierTechnische Universität München, Klinikum rechts der Isar, Department of Neurology, Ismaninger Str. 22, 81675 Munich, Germany+49 89 4140 4601; +49 89 4140 7681; [email protected]
, MD,
Bernhard HemmerTechnische Universität München, Klinikum rechts der Isar, Department of Neurology, Ismaninger Str. 22, 81675 Munich, Germany+49 89 4140 4601; +49 89 4140 7681; [email protected];SyNergy – Munich Cluster for Systems Neurology, Schillerstr. 44, 80336 Munich, Germany;KKNMS – Krankheitsbezogenes Kompetenznetz Multiple Sklerose, Einsteinstr. 1, 81675 München, Germany
, MD &
Thomas KornTechnische Universität München, Klinikum rechts der Isar, Department of Neurology, Ismaninger Str. 22, 81675 Munich, Germany+49 89 4140 4601; +49 89 4140 7681; [email protected];SyNergy – Munich Cluster for Systems Neurology, Schillerstr. 44, 80336 Munich, Germany
, MD
Pages 503-513 | Published online: 28 Feb 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Emanuele D’Amico, Cinzia Caserta & Francesco Patti. (2015) Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives. Expert Review of Neurotherapeutics 15:3, pages 251-268.
Read now

Articles from other publishers (11)

Kim M. A. De Kleijn & Gerard J. M. Martens. (2020) Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System. International Journal of Molecular Sciences 21:12, pages 4229.
Crossref
Moira Paroni, Virginia Maltese, Marco De Simone, Valeria Ranzani, Paola Larghi, Chiara Fenoglio, Anna M. Pietroboni, Milena A. De Riz, Maria C. Crosti, Stefano Maglie, Monica Moro, Flavio Caprioli, Riccardo Rossi, Grazisa Rossetti, Daniela Galimberti, Massimiliano Pagani, Elio Scarpini, Sergio Abrignani & Jens Geginat. (2017) Recognition of viral and self-antigens by T H 1 and T H 1/T H 17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses. Journal of Allergy and Clinical Immunology 140:3, pages 797-808.
Crossref
Ai-Lan Nguyen, Melissa Gresle, Tessa Marshall, Helmut Butzkueven & Judith Field. (2017) Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. British Journal of Pharmacology 174:13, pages 1895-1907.
Crossref
Jens Geginat, Moira Paroni, Massimiliano Pagani, Daniela Galimberti, Raffaele De Francesco, Elio Scarpini & Sergio Abrignani. (2017) The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?. Trends in Immunology 38:7, pages 498-512.
Crossref
Corinna Steckner, Andreas Weber, Anne K. Mausberg, Maximilian Heininger, Felicitas Opdenhövel, Bernd C. Kieseier, Hans P. Hartung & Harald H. Hofstetter. (2016) Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37–50 and MOG35–55-induced EAE in C57BL/6 mice. Clinical Immunology 170, pages 22-30.
Crossref
Audrey Beringer, Melissa Noack & Pierre Miossec. (2016) IL-17 in Chronic Inflammation: From Discovery to Targeting. Trends in Molecular Medicine 22:3, pages 230-241.
Crossref
Patrick R. Burkett, Youjin Lee, Anneli Peters & Vijay K. Kuchroo. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 307 318 .
R. Eming. (2015) PemphigusPemphigus. Der Hautarzt 66:8, pages 574-582.
Crossref
Hirofumi Ochi. (2014) Mechanism of multiple sclerosis based on the clinical trial results of molecular targeted therapy. Clinical and Experimental Neuroimmunology 5, pages 6-15.
Crossref
Anders Svenningsson, Peter Sundstrom, Jonatan Salzer & Mattias Vagberg. (2014) MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study. Neurology 83:22, pages 2099-2100.
Crossref
Thomas Korn. (2014) How do Th17 cells mediate autoimmune inflammation in the central nervous system?. Clinical and Experimental Neuroimmunology 5:2, pages 120-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.